𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Synthesis and Biological Evaluation of Novel 4-Substituted 1-{[4-(10,15,20-Triphenylporphyrin-5-yl)phenyl]methylidene}thiosemicarbazides as New Class of Potential Antiprotozoal Agents

✍ Scribed by Abdul R. Bhat; Fareeda Athar; Robyn L. Van Zyl; Chien-Teng Chen; Amir Azam


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
228 KB
Volume
5
Category
Article
ISSN
1612-1872

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

A novel series of 4‐substituted 1‐{[4‐(10,15,20‐triphenylporphyrin‐5‐yl)phenyl]methylidene}thiosemicarbazide, 4a4n, was synthesized in 9–21% yield by the condensation of 4‐(10,15,20‐triphenylporphyrin‐5‐yl)benzaldehyde (3) with various substituted thiosemicarbazides in presence of catalytic amount of AcOH. These compounds were assayed for in vitro antiamoebic activity, and the results showed that out of 14 compounds 9 were found with IC~50~ values lower than metronidazole corresponding to 1.05‐ to 4.7‐fold increase in activity. MTT Assay showed that all the compounds are nontoxic to human kidney epithelial cell line. 4‐(m‐Toluidinyl)‐1‐{[4‐(10,15,20‐triphenylporphyrin‐5‐yl)phenyl]methylidene}thiosemicarbazide (4h) showed the highest antiamoebic activity with least cytotoxicity. Some of the compounds were screened for their antimalarial activities and ability to inhibit β‐haematin formation, but none of them showed an activity better than chloroquine and quinine. Only one compound out of six showed an activity comparable to standard drug.


📜 SIMILAR VOLUMES


Synthesis and Biological Evaluation of 4
✍ Pitta Bhaskar Reddy; Satyam Kumar Agrawal; Swaran Singh; Bilal A. Bhat; Ajit K. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB

## Abstract A series of novel 4__β__‐[(4‐substituted)‐1,2,3‐triazol‐1‐yl]podophyllotoxin derivatives were synthesized by employing Cu^I^‐catalyzed click chemistry and evaluated for their anticancer activity against a panel of seven human cancer cell lines (HT‐29, HCT‐15, 502713, HOP‐62, A‐549, MCF‐